Literature DB >> 28954283

Editorial: Targeting MYB Oncogene Expression in Adenoid Cystic Carcinoma.

Scott A Ness1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28954283      PMCID： PMC7191885          DOI： 10.1093/jnci/djx054

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  31 in total

1.  The interferon regulatory factors 1 and 2 bind to a segment of the human c-myb first intron: possible role in the regulation of c-myb expression.

Authors:  L Manzella; R Gualdi; D Perrotti; N C Nicolaides; G Girlando; M A Giuffrida; A Messina; B Calabretta
Journal:  Exp Cell Res       Date:  2000-04-10       Impact factor: 3.905

2.  Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma.

Authors:  Eleni M Rettig; C Conover Talbot; Mark Sausen; Sian Jones; Justin A Bishop; Laura D Wood; Collin Tokheim; Noushin Niknafs; Rachel Karchin; Elana J Fertig; Sarah J Wheelan; Luigi Marchionni; Michael Considine; Shizhang Ling; Carole Fakhry; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Patrick K Ha; Nishant Agrawal
Journal:  Cancer Prev Res (Phila)       Date:  2016-02-09

3.  Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance.

Authors:  Yoshitsugu Mitani; Jie Li; Pulivarthi H Rao; Yi-Jue Zhao; Diana Bell; Scott M Lippman; Randal S Weber; Carlos Caulin; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2010-08-11       Impact factor: 12.531

4.  Whole exome sequencing of adenoid cystic carcinoma.

Authors:  Philip J Stephens; Helen R Davies; Yoshitsugu Mitani; Peter Van Loo; Adam Shlien; Patrick S Tarpey; Elli Papaemmanuil; Angela Cheverton; Graham R Bignell; Adam P Butler; John Gamble; Stephen Gamble; Claire Hardy; Jonathan Hinton; Mingming Jia; Alagu Jayakumar; David Jones; Calli Latimer; Stuart McLaren; David J McBride; Andrew Menzies; Laura Mudie; Mark Maddison; Keiran Raine; Serena Nik-Zainal; Sarah O'Meara; Jon W Teague; Ignacio Varela; David C Wedge; Ian Whitmore; Scott M Lippman; Ultan McDermott; Michael R Stratton; Peter J Campbell; Adel K El-Naggar; P Andrew Futreal
Journal:  J Clin Invest       Date:  2013-06-17       Impact factor: 14.808

5.  Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck.

Authors:  Marta Persson; Ywonne Andrén; Joachim Mark; Hugo M Horlings; Fredrik Persson; Göran Stenman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

6.  Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.

Authors:  Kathryn J Brayer; Candace A Frerich; Huining Kang; Scott A Ness
Journal:  Cancer Discov       Date:  2015-12-02       Impact factor: 39.397

Review 7.  Myb proteins: angels and demons in normal and transformed cells.

Authors:  Ye Zhou; Scott A Ness
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

8.  Single molecule analysis of c-myb alternative splicing reveals novel classifiers for precursor B-ALL.

Authors:  Ye E Zhou; John P O'Rourke; Jeremy S Edwards; Scott A Ness
Journal:  PLoS One       Date:  2011-08-11       Impact factor: 3.240

9.  Genomic landscape of adenoid cystic carcinoma of the breast.

Authors:  Luciano G Martelotto; Maria R De Filippo; Charlotte K Y Ng; Rachael Natrajan; Laetitia Fuhrmann; Joanna Cyrta; Salvatore Piscuoglio; Huei-Chi Wen; Raymond S Lim; Ronglai Shen; Anne M Schultheis; Y Hannah Wen; Marcia Edelweiss; Odette Mariani; Göran Stenman; Timothy A Chan; Pierre-Emmanuel Colombo; Larry Norton; Anne Vincent-Salomon; Jorge S Reis-Filho; Britta Weigelt
Journal:  J Pathol       Date:  2015-07-14       Impact factor: 7.996

10.  CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of MYB and MCL-1 expression.

Authors:  Partha Mitra; Ren-Ming Yang; James Sutton; Robert G Ramsay; Thomas J Gonda
Journal:  Oncotarget       Date:  2016-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.